article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

27 There is moderate evidence for the use of cannabinoids for sleep and limited evidence for use in psychiatric conditions, such as post-traumatic stress disorder, depression, anxiety, and psychosis; appetite stimulation and weight gain; and no evidence for cancer treatment. Moderate evidence exists for the use of cannabis for sleep.

article thumbnail

Minorities in cannabis, with Steven Philpott Jr.

The Cannigma

CP: Catalog, like a magazine? Is this as needed for sleep? They’re college athletes, or they’re not sleeping, their bodies aren’t recovering. And proficiency testing right now, because of the DEA is very limited in what can get sent out. And I realized that that “as needed”, was very subjective, right?